AMEX : HTBX

Heat Biologics, Inc.

$2.38 USD

$0.01 (0.42%)

Volume
43.61K
Average Volume
155.1K
Market Capitalization
$61.07M
P/E Ratio
-1.87
Dividend Yield
0.00%
Price Target
Year High
$10.85
Year Low
$1.60
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.00
Company Overview

AMEX

Jeffrey Wolf

Biotechnology

Healthcare

HTBX

49

US

USD

https://www.heatbio.com

19192407133

42237K300

0001476963

Liquidity Metrics

-136245.71

0.00

-0.01

0.00

0.00

Sales & Valuation

$2.11M

23.67

-1.09

0.00

-159497.29

Profitability

-$1.41

-$35.4M

-2378.34%

-2576.28%

35.52%

-29.54%

P/E Metrics

-1.87

0.18

0.18

Analyst Price Target & Rating

N/A

0/5

8 Analysts

%

Poll Results

About Heat Biologics, Inc. (AMEX:HTBX) Stock

Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrolling patients for its Phase II trial targeting advanced non-small cell lung cancer, while HS-130 is ... currently in a Phase I clinical trial for advanced solid tumors. Furthermore, PTX-35, a novel T-cell co-stimulator agonist antibody that acts on DR3/TNFRSF25, is being evaluated in a Phase I clinical trial for diverse immunotherapy applications. The company is also advancing a COVID-19 vaccine, which is currently in the preclinical stage. Heat Biologics, Inc. has partnered with Dr. James Shapiro at the University of Alberta to develop a surrogate mouse version of PTX-35. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.

Frequently Asked Questions

What is the current Heat Biologics, Inc. (HTBX) stock price?

Heat Biologics, Inc.(AMEX:HTBX) stock price is $2.38 in the last trading session. During the trading session, HTBX stock reached the peak price of $2.48 while $2.33 was the lowest point it dropped to. The percentage change in HTBX stock occurred in the recent session was 0.42% while the dollar amount for the price change in HTBX stock was $0.01.

HTBX's industry and sector of operation?

The AMEX listed HTBX is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of HTBX?

|
|
|
|
|

How many employees does HTBX have?

Number of HTBX employees currently stands at 49. HTBX operates from 627 DAVIS DRIVE, SUITE 400, Morrisville, NC 27560, US.

Link for HTBX official website?

Official Website of HTBX is: https://www.heatbio.com

How do I contact HTBX?

HTBX could be contacted at phone #19192407133 and can also be accessed through its website. HTBX operates from 627 DAVIS DRIVE, SUITE 400, Morrisville, NC 27560, US.

How many shares of HTBX are traded daily?

The average number of HTBX shares traded daily for last 3 months was 155.1K.

What is the market cap of HTBX currently?

The market value of HTBX currently stands at $61.07M with its latest stock price at $2.38